Exosomes derived from mesenchymal stem cells: Heralding a new treatment for periodontitis?
Elnaz Mousavi,Armin Khosravi,Somaye Salari Sedigh,Sayad Ayub Tabatabaei Mayanei,Morteza Banakar,Moslem Karimzadeh,Amirhossein Fathi
DOI: https://doi.org/10.1016/j.tice.2023.102070
IF: 2.586
2023-06-01
Tissue and Cell
Abstract:Periodontitis, as a complex inflammatory disorder, is characterized by continuous destruction of the teeth-supporting components, like alveolar bone and periodontal ligament, and affects a great percentage of individuals over the world. Also, this oral disease is linked with multiple serious illnesses, e.g., cardiovascular disorders, diabetes, and oral cancer; thus, exerting efficient therapy for periodontitis is necessary. Unfortunately, the current therapies for the disease (e.g., surgical and nonsurgical methods) have not reflected enough effectiveness against periodontitis. At present, mesenchymal stem cell (MSC)-based remedy has created new hope for curating different diseases; however, MSCs have no capability to engraft into the chosen tissue, and the tumorigenic influences of MSCs are still the main concern. Interestingly, documents have revealed that MSC-derived mediators, like exosomes, which their exploitation is more feasible than intact MSCs, can be an effective therapeutic candidate for periodontitis. Therefore, in this study, we will review evidence in conjunction with their possible curative impacts on periodontitis cases.
cell biology,anatomy & morphology